Targeting intracellular oncoproteins with antibody therapy or vaccination. - Wikidata - awgldk - TriplyDB

Targeting intracellular oncoproteins with antibody therapy or vaccination.

Targeting intracellular oncoproteins with antibody therapy or vaccination.

http://www.wikidata.org/entity/Q39477768

about

Survivin: a unique target for tumor therapy Specificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancer IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents.Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes.Intravital and whole-organ imaging reveals capture of melanoma-derived antigen by lymph node subcapsular macrophages leading to widespread deposition on follicular dendritic cells.IgE-based immunotherapy of cancer: challenges and chances.Raynaud's phenomenon, inflammatory arthritis, and weight loss: pay attention to the man behind the curtain.Phosphatase of regenerating liver: a novel target for cancer therapy.Feasibility analysis of p62 (SQSTM1)-encoding DNA vaccine as a novel cancer immunotherapy.Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice.Hidden immunotherapy targets challenge dogma The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development.Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.PRL3-zumab, a first-in-class humanized antibody for cancer therapy.Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector.Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.Antibody-based immunotherapy of cancer.Electro-gene-transfer as a new tool for cancer immunotherapy in animals.Preclinical vaccines against mammary carcinoma.Monoclonal antibodies as therapeutics in human malignancies.Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases.High folic acid diet enhances tumour growth in PyMT-induced breast cancer.Therapeutic Antibodies against Intracellular Tumor Antigens Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway.Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy.Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis.

P2860

Q26747332-9EB36331-709C-4F62-836A-182E6ED098A8 Q26853171-CB01B7F7-8B8B-424D-BB76-BE451D0FE6EC Q28069295-BD484C1F-083B-472C-BC49-F7D71D81C8E6 Q28660580-54070C3D-53B4-4BFC-A4D2-5D5AD3641FCB Q30457615-9296D28B-3E15-4692-8CE9-6F623C38E1A0 Q30558949-E1E8C8E5-CF12-4211-BC96-0A754ECB506C Q30627418-F5E07DAD-0509-473E-A56C-3815A85E61A8 Q33619979-5A8716EE-1FD8-4417-A84D-492D5EFBB502 Q34128485-67E30754-1EB9-4ADD-AC93-CF4DA2DD7906 Q34437541-CDFDF568-AA15-442B-8B13-2ED40CC4D0D3 Q35626579-6F4C6063-72E9-4EFA-8BBE-E0DBB7518153 Q35889827-994CB5C3-F6BF-4A34-8627-9F5A92FA8CA1 Q36184951-D90BA801-57F2-4D22-A51D-7A38BDEBF61F Q36510458-ED1C85A5-9147-4AD5-9B70-D400B7754B53 Q36864003-1444E8D5-6AF1-4A06-803E-11B04BE7D3EC Q37236903-C6080FE8-F440-44C8-A344-534689D15DE0 Q37277211-587EFDC7-8B70-43F8-BB70-EE3886CC873D Q37352107-836943E8-0717-4449-9767-6DF96292A517 Q37381632-0DC77428-DFDE-46D5-B382-21B30B9BB2CB Q37659113-C5C13AAD-391C-4C22-B77B-D8D89FCDFB17 Q37994278-FD2CCA3C-4BDC-48C3-ADA6-474DAE3A865B Q38055259-E59F887D-86CB-43AA-A426-300BFA6071F4 Q38160252-B6DF5684-99CA-4BC8-B044-C8FA91DED357 Q38206275-6B0971E3-15FB-4A39-9620-1B2542646BC2 Q38644355-9920BF4D-9300-4063-B9B2-646978B1B2C2 Q39646994-D0F78E10-582D-4C97-8500-48421F9B623C Q40353665-80E5639F-F114-4D37-B97F-272C2B6FF6E7 Q41462883-2F32C661-1944-467C-AEF6-450AD7B8B704 Q43522873-95B8D2DA-367B-45A6-BDAB-213E220E5858 Q47105994-DD8538C3-DC82-45EA-A8BD-C7C5419A783E Q47335259-066B59C8-981A-40E4-9350-6778E292077E Q48103763-8B30D8BB-EA73-4E36-85A0-F70FE073D777 Q48825054-EC46284E-840A-4FEB-BCA5-F560E5A1F755

P2860

Targeting intracellular oncoproteins with antibody therapy or vaccination.

http://www.wikidata.org/entity/Q39477768

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Targeting intracellular oncoproteins with antibody therapy or vaccination.

@en

Targeting intracellular oncoproteins with antibody therapy or vaccination.

@nl

type

label

Targeting intracellular oncoproteins with antibody therapy or vaccination.

@en

Targeting intracellular oncoproteins with antibody therapy or vaccination.

@nl

prefLabel

Targeting intracellular oncoproteins with antibody therapy or vaccination.

@en

Targeting intracellular oncoproteins with antibody therapy or vaccination.

@nl

P1433

Q39477768-13A71E0B-A5A2-4DC8-BE95-FCCC26C6AA21

P1476

Q39477768-035DA011-8917-4C3B-80E7-624D23A8A0F1

P2093

Q39477768-14AF3D44-7F5D-4852-8635-8C3415FA330C

Q39477768-1873E2E8-8645-4F71-B2B7-E375A978D6E2

Q39477768-2EE83E79-8B5B-4B1A-A69A-84F4BFF6B0CD

Q39477768-61E7F065-1B63-4F1A-B928-50387F66B8D9

Q39477768-9DF6686C-F6A2-46E8-9934-C59DBE94E054

Q39477768-B78B042A-18FD-4154-9976-B582E1F8F98B

Q39477768-E17A87D4-F290-4B73-94C6-6484AB70C46E

Q39477768-E931CEE6-6636-4BC1-AFCB-472B54BBB1E2

Q39477768-F4C7316C-3E85-46BC-8C1B-7F1BB957BF23

P2860

Q39477768-1322030E-2CEF-47C2-BB20-B25A05F4B95A

Q39477768-2B1500CD-8294-4C0E-982B-2DA01F328EB7

Q39477768-32C04A40-BB44-443F-8897-30B7E0E28E0C

Q39477768-351A2879-1638-41B1-9C1A-F17148C8D144

Q39477768-3DDA1395-C205-4FFF-B722-6136C6E5EEDB

Q39477768-4370DB64-7941-45BF-B15E-278F919B6B12

Q39477768-61A63BD9-30CE-40D7-A5AC-73E0CDD7BE52

Q39477768-62ECD247-EC31-4EA9-8528-9205EB9C775F

Q39477768-6714462B-109A-4DE9-A041-B23FB9C9B639

Q39477768-6D36711F-51D6-40AC-827E-EB8B93C2DAC3

P304

Q39477768-B8DC0CD9-261F-40B2-B876-DF4926EF66DE

P31

Q39477768-7464310B-4C09-42D5-B6E7-8DCFCA6600BE

P356

Q39477768-AFC045CC-8B85-446C-BA80-E8E9B2336B77

P407

Q39477768-1683A0C5-232F-4A35-93B4-6EB8AB5EA714

P433

Q39477768-102AB103-2D1E-4D5C-92DB-1E089FC0CDC2

P478

Q39477768-896B4530-F8D9-4ABA-A715-22276E885FDF

P577

Q39477768-338767CA-39C1-48CD-B0AD-8110FE35B20D

P698

Q39477768-8FCFDD62-0F89-4371-ACC5-FB0805D70BF9

P921

Q39477768-CF17F60A-932C-48F0-9ACE-51A07B25640D

P356

SCITRANSLMED.3002296

P1433

Science Translational Medicine

P1476

Targeting intracellular oncoproteins with antibody therapy or vaccination.

@en

P2093

Abdul Qader O Al-Aidaroos

http://www.w3.org/2001/XMLSchema#string

Caixia Huang

http://www.w3.org/2001/XMLSchema#string

Cheng Peow Bobby Tan

http://www.w3.org/2001/XMLSchema#string

Cheng William Hong

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Jing Ping Tang

http://www.w3.org/2001/XMLSchema#string

Ke Guo

http://www.w3.org/2001/XMLSchema#string

Leyon Varghese

http://www.w3.org/2001/XMLSchema#string

Qi Zeng

http://www.w3.org/2001/XMLSchema#string

P2860

Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome

A phosphatase associated with metastasis of colorectal cancer

Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases

Protein tyrosine phosphatases in the human genome

PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

Systemic spread is an early step in breast cancer

Breast cancer metastasis: markers and models

P304

99ra85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3002296

http://www.w3.org/2001/XMLSchema#string

P407

P433

99

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21900592

http://www.w3.org/2001/XMLSchema#string

P921